Holy Name Medical Center Appoints Nancy Palamara, Vice President, Diagnostics and Therapeutics
Holy Name Medical Center today announced the appointment of Nancy Palamara, Pharm D., as vice president of diagnostics and therapeutics.
In this newly created position, Palamara oversees all aspects of diagnostic and therapeutic services and operations, including Holy Name's institutional and retail pharmacy, as well as the departments of laboratory medicine, radiology, rehabilitation services, respiratory therapy, sleep medicine, and infusion services.
Palamara most recently served as director of pharmacy, infusion therapy, and Holy Name's Alfiero & Lucia Palestroni Foundation Multiple Sclerosis Center. Her leadership and expertise played a crucial role in Holy Name's response to the COVID-19 crisis, from surge planning to managing medications and supplies. The hospital was the epicenter of New Jersey's outbreak and one of the first and hardest hit hospitals in the country.
"Nancy's consistent focus on operational effectiveness, safety and efficiency, patient-centered care, and volume growth has allowed us to remain competitive and cost-effective," said Michael Maron, President and CEO of Holy Name Medical Center. "Her leadership and expertise will be key as we enter this new era of healthcare, especially given the wide-reaching effects of the pandemic."
Palamara joined Holy Name in 1992 as a pharmacy technician and later was promoted to clinical staff pharmacist. In 2002, she was named assistant director of pharmacy services and by 2016 held the dual role of director of pharmacy services and director of infusion therapy. Two years later, she took on the additional role of director of the MS Center.
Over the course of her career at Holy Name, Palamara has volunteered her time and expertise to staff at Holy Name's sister hospital in Milot, Haiti, and served as an adjunct faculty member for Bergen Community College's Allied Health Department.
"Collaboration with our clinical and non-clinical teams will continue to keep Holy Name on the forefront of innovation in care, from diagnostics to treatment," said Palamara. "I am excited to take on this new opportunity to further Holy Name's reputation as one of the state's leading providers."
Palamara earned both her bachelor of science degree in pharmacy and her doctor of pharmacy degree from Rutgers, The State University of New Jersey.
She has presented at local and national seminars and conferences. Palamara is currently a member of The American Society of Health-System Pharmacists, and served as president of its NJ affiliate organization. She is also the recipient of numerous awards and accolades, and was most recently honored with the Gregory A. Santora Pharmacist of the Year Leadership Award by the New Jersey Society of Health-System Pharmacists.